ReviewCells2026
Genetic and Epigenetic Regulation of Cardiac Development: An Integrative View from Embryo to Human Pluripotent Stem Cell Models.
Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiogenesis is an exquisitely complex developmental process that unfolds through a series of tightly regulated and dynamic morphogenetic events. Proper heart development demands meticulous coordination of multiple signaling pathways, transcription factors and epigenetic mechanisms at every stage of cardiogenesis. Better understanding of the molecular regulation of cardiac development and the advances in the field of stem cell technology have paved way to the development of robust differentiation strategies to generate cardiomyocytes from pluripotent stem cells. This review provides a concise overview of key processes underlying human cardiac development, with a focus on their genetic and epigenetic regulation. It further discusses the generation of cardiomyocytes from human pluripotent stem cells, highlighting state-of-the-art differentiation protocols and detailing the genetic and epigenetic mechanisms that govern in vitro cardiomyocyte formation. By integrating insights from both in vivo human cardiac development and in vitro pluripotent stem cell-derived cardiomyocyte models, this article offers a comprehensive perspective on how embryonic cardiogenesis can be recapitulated in vitro, deepening our understanding of the molecular framework governing cardiomyocyte formation. Importantly, these insights hold significant translational potential for advancing disease modeling, drug discovery, and regenerative therapies for cardiovascular diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.